A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol

A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol

Abstract Background The U.S. Food and Drug Administration can set standards for cigarettes that could include reducing their nicotine content. Such a standard should improve public health without causing unintended serious consequences for sub-populations. This study evaluates the effect of progress...

Full description

Bibliographic Details
Main Authors: Sophia I. Allen, Jonathan Foulds, Gladys N. Pachas, Susan Veldheer, Corinne Cather, Nour Azzouz, Shari Hrabovsky, Ahmad Hameed, Jessica Yingst, Erin Hammett, Jennifer Modesto, Nicolle M. Krebs, Junjia Zhu, Jason Liao, Joshua E. Muscat, John Richie, A. Eden Evins
Format: Article
Language:English
Published: BMC 2017-01-01
Series:BMC Public Health
Subjects:
Tobacco
Cigarettes
RCT
Mood
Anxiety
Spectrum
Online Access:http://link.springer.com/article/10.1186/s12889-016-3946-4

Internet

http://link.springer.com/article/10.1186/s12889-016-3946-4

Similar Items